Our Team


Dr. Robert Ang, CEO of Vor Biopharma copy.png

Robert Ang, MD, MBA
Chief Executive Officer

Dr. Ang brings experience as a senior biotech executive and formerly a physician, venture capitalist and strategy consultant. Prior to Vor, Dr. Ang was Chief Business Officer at Neon Therapeutics, part of the early team establishing the company prior to its Series A investment through IPO. …


Bharatt%2BChowrira%252C%2BPureTech%2BHealth.jpg

Bharatt chowrira, J.D., Ph.D.
Board of Directors

Bharatt Chowrira, JD, PhD, has been the President and Chief of Business and Strategy at PureTech Health since March 2017. Prior to joining PureTech Health, Dr. Chowrira was the President of Synlogic ...


portrait Lundberg.jpeg

bill lundberg, m.d.
board of directors

Dr. Bill Lundberg is a medical oncologist with more than 15 years of experience managing and leading biotechnology research and development. Most recently, Dr. Lundberg served as Chief Scientific Officer at CRISPR Therapeutics, establishing the company in Cambridge, Mass. …


Kush_WEBSITE.jpg

Kush Parmar, M.D., Ph.D.
Executive Chairman, Board of Directors

Kush M Parmar, M.D., Ph.D., is a managing partner at 5AM Ventures. Dr. Parmar serves as a director on the Boards of Akouos, Arvinas, Entrada, Homology, and Rally Bio. He previously served as acting VP of strategy and corporate development at Novira (acquired by J&J) and served as Board Member or Observer for Achaogen, Audentes, Envoy (acquired by Takeda), and scPharmaceuticals ...


Resnick_website.jpg

Josh Resnick, M.d.
Board of directors

Josh Resnick, M.D., is a managing director at RA Capital Management. Dr. Resnick’s primary responsibility at RA Capital is to lead early-stage private investments in and oversee the creation of new companies developing drugs, medical devices, diagnostics and research tools …